In 2024, approximately 1,100,000 people were living with HIV in Brazil, unchanged from the number recorded a year earlier. The number of patients with HIV in the South American country increased by approximately 15 percent during the period analyzed. Brazil’s approach to prevention With an increasing number of people living with HIV, the Brazilian government has implemented various policies related to prevention, diagnosis, and treatment. Among preventative measures, information campaigns, needle exchange programs, and the use of pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) have been carried out throughout the country, allowing for a contained epidemic. Antiretroviral therapy (ART) As of 2022, an increasing number of Brazilians living with the disease reported receiving antiretroviral therapy. That year, approximately three in every four people living with HIV were treated with ART. In comparison, less than 60 percent of HIV patients had access to the treatment in 2015 and less than 40 percent in 2010.

Actual value and historical data chart for Brazil Womens Share Of Population Ages 15 Living With Hiv Percent

Antiretroviral therapy (ART) is a type of medical treatment used to restrict the development of a targeted virus and treat infections. This therapy is widely used in the management of HIV/AIDS disease. In 2024, ******* people living with HIV received treatment with antiretroviral drugs in Brazil. This figure equals around ** percent of the total population living with HIV in the South American country.

Actual value and historical data chart for Brazil Prevalence Of Hiv Total Percent Of Population Ages 15 49

Brazil BR: Prevalence of HIV: Female: % Aged 15-24 data was reported at 0.200 % in 2017. This stayed constant from the previous number of 0.200 % for 2016. Brazil BR: Prevalence of HIV: Female: % Aged 15-24 data is updated yearly, averaging 0.200 % from Dec 1990 (Median) to 2017, with 28 observations. The data reached an all-time high of 0.200 % in 2017 and a record low of 0.100 % in 1991. Brazil BR: Prevalence of HIV: Female: % Aged 15-24 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Brazil – Table BR.World Bank.WDI: Social: Health Statistics. Prevalence of HIV, female is the percentage of females who are infected with HIV. Youth rates are as a percentage of the relevant age group.;UNAIDS estimates.;Weighted average;In many developing countries most new infections occur in young adults, with young women especially vulnerable.

In 2020, the prevalence of HIV among men who have sex with other men amounted to **** percent in Brazil. That year, HIV prevalence among sex workers reached about *** percent, while among people who injected drugs, HIV prevalence was nearly six percent in the country. There were around *** thousand people diagnosed with HIV in Brazil that year.

In 2024, the estimated number of new HIV cases in Brazil amounted to around 55,000, down from approximately 62,000 new HIV diagnoses registered a year before. Brazil reported the highest number of patients living with HIV among selected countries in Latin America.

Brazil BR: Incidence of HIV: per 1,000 Uninfected Population Aged 15-49 data was reported at 0.390 Ratio in 2022. This stayed constant from the previous number of 0.390 Ratio for 2021. Brazil BR: Incidence of HIV: per 1,000 Uninfected Population Aged 15-49 data is updated yearly, averaging 0.390 Ratio from Dec 1990 (Median) to 2022, with 33 observations. The data reached an all-time high of 0.410 Ratio in 1999 and a record low of 0.360 Ratio in 1990. Brazil BR: Incidence of HIV: per 1,000 Uninfected Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Brazil – Table BR.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations ages 15-49 expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].

In 2018, São Paulo was the Brazilian state with the highest number of HIV-positive patients in the country, with ***** cases. It was followed by Rio de Janeiro, with around *** thousand cases and Rio Grande do Sul, with nearly *** thousand patients.

BackgroundHIV-1 subtype B and subtype F are prevalent in the AIDS epidemic of Brazil. Recombinations between these subtypes have generated at least four BF circulating recombinant forms (CRFs). CRF28_BF and CRF29_BF are among the first two BF recombinants being identified in Brazil and they contributed significantly to the epidemic. However, the evolution and demographic histories of the CRFs are unclear. Methodology/Principal FindingsA collection of gag and pol sequences sampled within Brazil was screened for CRF28_BF-like and CRF29_BF-like recombination patterns. A Bayesian coalescent framework was employed to delineate the phylogenetic, divergence time and population dynamics of the virus having CRF28_BF-like and CRF29_BF-like genotype. These recombinants were phylogenetically related to each other and formed a well-supported monophyletic clade dated to 1988–1989. The effective number of infections by these recombinants grew exponentially over a five-year period after their emergence, but then decreased toward the present following a logistic model of population growth. The demographic pattern of both recombinants closely resembles those previously reported for CRF31_BC. ConclusionsWe revealed that HIV-1 recombinants of the CRF28_BF/CRF29_BF clade are still circulating in the Brazilian population. These recombinants did not exhibit a strong founder effect and showed a decreasing prevalence in the AIDS epidemic of Brazil. Our data suggested that multiple URFs may also play a role in shaping the epidemic of recombinant BF HIV-1 in the region.

Forecast: HIV-Positive Tuberculosis Treatment Success Rate in Brazil 2022 - 2026 Discover more data with ReportLinker!

This horizontal bar chart displays incidence of HIV (per 1,000 uninfected population) by region using the aggregation average, weighted by population in Brazil. The data is about countries per year.

Brazil has a concentrated HIV epidemic and men who have sex with men (MSM) are disproportionately affected. Yet, no data is available on the HIV care cascade for this population. This study aimed to assess the HIV care cascade among MSM newly diagnosed through innovative testing strategies in Rio de Janeiro. Data from 793 MSM and travestites/transgender women (transwomen) tested for HIV at a non-governmental LGBT organization and a mobile testing unit located at a gay friendly venue were analyzed. A 12-month-after-HIV-diagnosis-censored cohort was established using CD4, viral load and combination antiretroviral therapy (cART) longitudinal data from those diagnosed with HIV. A cross-sectional HIV care cascade was built using this data. The relative risks of achieving each cascade-stage were estimated using generalized linear models according to age, self-declared skin-color, education, history of sexually transmitted diseases (STD), drug use and prior HIV testing. From Jan-2013 to Jan-2014, 793 MSM and transwomen were tested, 131 (16.5%) were HIV-infected. As of January 2015, 95 (72.5%) were linked to HIV care, 90 (68.7%) were retained in HIV care, 80 (61.1%) were on cART, and 50 (38.2%) were virally suppressed one year after HIV diagnosis. Being non-white (Relative risk [lower bound; upper bound of 95% confidence interval] = 1.709 [1.145; 2.549]) and having a prior HIV-test (1.954 [1.278; 2.986]) were associated with an HIV-positive diagnosis. A higher linkage (2.603 [1.091; 6.211]) and retention in care (4.510 [1.880; 10.822]) were observed among those who were older than 30 years of age. Using community-based testing strategies, we were able to access a high-risk MSM population and a small sample of transwomen. Despite universal care coverage and the test-and-treat policy adopted in Brazil, the MSM cascade of care indicates that strategies to increase linkage to care and prompt cART initiation targeted to these populations are critically needed. Interventions targeting non-white and young MSM should be prioritized.

The aim of this study was to assess risk factors associated with low levels of HIV testing among MSM recruited through respondent driven sampling (RDS) in Brazil. Of 3,617 participants, 48.4% had never tested previously for HIV. A logistic model indicated that younger age, lower socioeconomic class, education, poor HIV/AIDS knowledge, no history of cruising, and having been tested during the study were characteristics independently associated with low levels of previous HIV testing. The HIV testing rate among MSM in Brazil is still low in spite of the availability of a large number services providing universal and free access to HIV/AIDS diagnosis and treatment. To respond to low utilization, the authors propose a higher priority for testing for key populations such as MSM, expanded education, expanding testing sites and a welcoming and nonjudgmental environment in health services.

Abstract: The cascade of care for people living with HIV infection (PLHIV) describes steps in diagnosis, linkage and retention in care, as well as the provision and success of combination antiretroviral therapy (cART). The aim of this study was to evaluate the rates regarding the retention in care, on cART, and suppressed viral load for PLHIV attended at a Brazilian public health network. Data on PLHIV from 116 cities of Paraná, Southern Brazil, attended from 2012 to 2015, were retrospectively collected through the Laboratory Tests Control System (SISCEL). The number of PLHIV related to care increased about 22.5% from 2012 to 2015 (4,106 to 5,030 individuals). The proportion of PLHIV retained in care showed a trend toward stabilization around 81.7-86.9%. Every year, the use of cART increased up to 90.3% for PLHIV retained in care. Viral load suppression was achieved by 72.8% of patients on cART and 57.1% by those linked to care. Retention in care and HIV viral suppression were more likely to occur in older PLHIV than younger ones; similarly, patients living in medium-sized cities were more susceptible to these factors than in large- or small-sized cities. In conclusion, the study showed a high level of retention in care and HIV suppression on cART, as well as emphasized that current efforts for treating already-infected PLHIV remain a challenge for our health public institutions and may contribute to highlight steps for improvement of the HIV cascade of care in our population.

Forecast: Total HIV Incidence Rate in Brazil 2023 - 2027 Discover more data with ReportLinker!

This scatter chart displays incidence of HIV (per 1,000 uninfected population) against urban population living in areas where elevation is below 5 meters (% of total population) in Brazil. The data is about countries per year.

Brazil BR: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.600 % in 2022. This stayed constant from the previous number of 0.600 % for 2021. Brazil BR: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.400 % from Dec 1990 (Median) to 2022, with 33 observations. The data reached an all-time high of 0.600 % in 2022 and a record low of 0.200 % in 1996. Brazil BR: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Brazil – Table BR.World Bank.WDI: Social: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.;UNAIDS estimates.;Weighted average;

In 2024, around *** percent of the adult population aged 15 to 49 years in Brazil was living with HIV, an increase compared to the *** percent HIV prevalence reported in 1990. This figure has remained stable throughout the analyzed period. In the last year, an estimated of *********** patients were living with HIV in the South American country.

Antiretroviral therapy coverage (% of people living with HIV) in Brazil was reported at 73 % in 2024, according to the World Bank collection of development indicators, compiled from officially recognized sources. Brazil - Antiretroviral therapy coverage (% of people with advanced HIV infection) - actual values, historical data, forecasts and projections were sourced from the World Bank on November of 2025.